ProShare Advisors’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,177
| Closed | -$35K | – | 2350 |
|
|
2021
Q3 | $35K | Buy |
+1,177
| New | +$35K | ﹤0.01% | 1985 |
|
|
2021
Q2 | – | Sell |
-1,678
| Closed | -$101K | – | 2404 |
|
|
2021
Q1 | $101K | Buy |
1,678
+76
| +5% | +$4.57K | ﹤0.01% | 2164 |
|
|
2020
Q4 | $84K | Buy |
1,602
+336
| +27% | +$17.6K | ﹤0.01% | 2009 |
|
|
2020
Q3 | $44K | Buy |
1,266
+34
| +3% | +$1.18K | ﹤0.01% | 1601 |
|
|
2020
Q2 | $107K | Buy |
+1,232
| New | +$107K | ﹤0.01% | 1564 |
|
|
2020
Q1 | – | Sell |
-1,382
| Closed | -$100K | – | 1568 |
|
|
2019
Q4 | $100K | Sell |
1,382
-92
| -6% | -$6.66K | ﹤0.01% | 1693 |
|
|
2019
Q3 | $90K | Sell |
1,474
-42
| -3% | -$2.56K | ﹤0.01% | 1563 |
|
|
2019
Q2 | $144K | Sell |
1,516
-192
| -11% | -$18.2K | ﹤0.01% | 1495 |
|
|
2019
Q1 | $139K | Buy |
1,708
+11
| +0.6% | +$895 | ﹤0.01% | 1533 |
|
|
2018
Q4 | $276K | Buy |
+1,697
| New | +$276K | ﹤0.01% | 1198 |
|